{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:12:39Z","timestamp":1789189959319,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.vph.2024.107367","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T07:22:52Z","timestamp":1710746572000},"page":"107367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Percutaneous coronary interventions versus coronary artery bypass graft surgery in coronary artery disease"],"prefix":"10.1016","volume":"155","author":[{"given":"David P.","family":"Taggart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vph.2024.107367_bb0005","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.athoracsur.2006.06.035","article-title":"Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know","volume":"82","author":"Taggart","year":"2006","journal-title":"Ann. Thorac. Surg."},{"issue":"40","key":"10.1016\/j.vph.2024.107367_bb0010","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1093\/eurheartj\/ehu213","article-title":"Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial","volume":"35","author":"Head","year":"2014","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.vph.2024.107367_bb0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacc.2016.04.034","article-title":"Long-term mortality after coronary revascularization in nondiabetic patients with multivessel disease","volume":"68","author":"Chang","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.vph.2024.107367_bb0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2018.11.001","article-title":"Long-term survival following multivessel revascularization in patients with diabetes: the FREEDOM follow-on study","volume":"73","author":"Farkouh","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.vph.2024.107367_bb0025","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jacc.2020.06.052","article-title":"Long-term survival after surgical or percutaneous revascularization in patients with diabetes and multivessel coronary disease","volume":"76","author":"Tam","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.vph.2024.107367_bb0030","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.vph.2024.107367_bb0035","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jamacardio.2020.0239","article-title":"Long-term outcomes in patients with severely reduced left ventricular ejection fraction undergoing percutaneous coronary intervention vs coronary artery bypass grafting","volume":"5","author":"Sun","year":"2020","journal-title":"JAMA Cardiol."},{"issue":"15","key":"10.1016\/j.vph.2024.107367_bb0040","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"REVIVED-BCIS2 Investigators. Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.vph.2024.107367_bb0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.vph.2024.107367_bb0050","first-page":"e4","article-title":"2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.vph.2024.107367_bb0055","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jacc.2007.09.067","article-title":"Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery","volume":"51","author":"Taggart","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"17","key":"10.1016\/j.vph.2024.107367_bb0060","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa0801441","article-title":"Stents versus coronary-artery bypass grafting for left main coronary artery disease","volume":"358","author":"Seung","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.vph.2024.107367_bb0065","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1161\/CIRCULATIONAHA.113.006689","article-title":"Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial","volume":"129","author":"Morice","year":"2014","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.vph.2024.107367_bb0070","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1056\/NEJMoa1909406","article-title":"Five-year outcomes after PCI or CABG for left main coronary disease","volume":"381","author":"Stone","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.vph.2024.107367_bb0075","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jacc.2020.08.016","article-title":"Implications of alternative definitions of Peri-procedural myocardial infarction after coronary revascularization","volume":"76","author":"Gregson","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10219","key":"10.1016\/j.vph.2024.107367_bb0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(19)32972-1","article-title":"Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial","volume":"395","author":"Holm","year":"2020","journal-title":"Lancet"},{"issue":"34","key":"10.1016\/j.vph.2024.107367_bb0085","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1093\/eurheartj\/ehaa135","article-title":"Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials","volume":"41","author":"Ahmad","year":"2020","journal-title":"Eur. Heart J."},{"issue":"10318","key":"10.1016\/j.vph.2024.107367_bb0090","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/S0140-6736(21)02334-5","article-title":"Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis","volume":"398","author":"Sabatine","year":"2021","journal-title":"Lancet"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189124000922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189124000922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T12:56:10Z","timestamp":1733403370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189124000922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":18,"alternative-id":["S1537189124000922"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2024.107367","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Percutaneous coronary interventions versus coronary artery bypass graft surgery in coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2024.107367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107367"}}